Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1997-05-06
1998-09-22
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 111, 424 165, 436 56, 436 57, 436504, 436545, 436804, 252625, 252645, A61K 5100, A61M 3614
Patent
active
058110720
ABSTRACT:
Additives are proposed for compositions comprising radiolabelled organic compounds e.g. 32P-labelled nucleotides. Stabilisers are selected from tryptophan, para-aminobenzoate, indoleacetate and the azole group. Dyes are selected from Sulphorhodamine B, Xylene Cyanol, Azocarmine B and New Coccine. Preferred compositions contain both stabiliser and dye.
REFERENCES:
patent: 3261747 (1966-07-01), Commerford
patent: 3673410 (1972-06-01), Waite et al.
patent: 4095950 (1978-06-01), Kahn
patent: 4390517 (1983-06-01), O'Brien et al.
patent: 4411881 (1983-10-01), Tzodikov
patent: 4451451 (1984-05-01), Rimmer
patent: 4769334 (1988-09-01), Fleming
patent: 4793987 (1988-12-01), Henderson et al.
patent: 4880615 (1989-11-01), Charleson
patent: 4959309 (1990-09-01), Dattagupta et al.
patent: 4966854 (1990-10-01), Fleming
patent: 5093105 (1992-03-01), Flanagan et al.
patent: 5101020 (1992-03-01), Fleming
patent: 5262175 (1993-11-01), Solanki
patent: 5308605 (1994-05-01), Kassis et al.
patent: 5332666 (1994-07-01), Prober et al.
patent: 5494654 (1996-02-01), Price et al.
patent: 5667763 (1997-09-01), Price et al.
patent: 5686058 (1997-11-01), Price et al.
Lewis, (1993) Hawley's Twelfth Edition Condensed Chemical Dictionary, p. 53 "Amino acid" and 842 nucleotide.
Chemical Abstracts, 111(11), Abstract No. 93463b (Sep. 11, 1989).
1976 New England Nuclear Catalog, p. 121 (1976).
Instruction Manual for Rianen Assay System, Prostatic Acid Phosphatase Medical Products Department (publication date not clear). Radioimmunoassay Kit, Catalog No. NEA-078, DuPont Medical Products Department (publication date not clear).
G.E. Abraham, Acta Endocrinologica, 75, Suppl. 183, 1-42 (1977).
G.E. Abraham et al., Handbook of Radioimmunoassay, G.E. Abraham, ed., 634, 635, 653 (1977).
A.C. Peacock et al., Biochemistry, 6, 1818-1827 (1967).
U.K. Laemmli, Nature, 227, 680, 681, 685 (1970).
A.M. Maxam et al., Proc. Natl. Acad. Sci. USA, 74, 500-560 (1977).
F. Sanger et al., J. Mol. Biol., 94, 441-448 (1975).
D. Ornstein et al., BioTechniques, 3, 476-480, 482, 483 (1985).
E.A. Evans, Radiotracer Techniques and Applications, vol. 1, E.A. Evans and M. Muramatsu, eds., Marcel Dekker, New York, 237-260 (1977).
Amersham Life Science Products 1991 (catalog), p. 2.111 (1991).
ICN Radiochemicals (catalog), pp. 7 and 45 (1985).
Buckley Elizabeth Margaret
May Christopher Charles
Price Roger Malcolm
Stone Timothy
Amersham Pharmacia Biotech UK Limited
Hollinden Gary E.
Jones Dameron
LandOfFree
Radiolabeled nucleotide formulations stored in an unfrozen state does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled nucleotide formulations stored in an unfrozen state, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled nucleotide formulations stored in an unfrozen state will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1619989